In vitro activity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics

por Kaplan, Nachum, Awrey, Donald, Bardouniotis, Elias, Berman, Judd, Yethon, Jeremy, Pauls, Henry W, Hafkin, Barry
Publicado 2013

Limitations of Murine Models for Assessment of Antibody-Mediated Therapies or Vaccine Candidates against Staphylococcus epidermidis Bloodstream Infection

por Cole, Leah E., Zhang, Jinrong, Kesselly, Augustus, Anosova, Natalie G., Lam, Hubert, Kleanthous, Harry, Yethon, Jeremy A.
Publicado 2016